Creative Medical Technology Holdings Inc expected to post a loss of $1.16 a share - Earnings Preview
11/05/2024 24:45
* Creative Medical Technology Holdings Inc CELZ.OQ
CELZ.O is
expected to show no change in quarterly revenue when it reports
results on May 10 for the period ending January 1 0001
*
* LSEG's mean analyst estimate for Creative Medical
Technology
Holdings Inc is for a loss of $1.16 per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts had fallen by
about 0.9%
in the last three months.
* Wall Street's median 12-month price target for Creative
Medical
Technology Holdings Inc is $30.00, above its last closing
price of $4.35.
This summary was machine generated May 10 at 23:44 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Creative Medical Technology Holdings
See all newsBrief: Creative Medical Technology Buys 4 Million Biodefense Shares For $200,000 Cash And 1 Million Shares On Sept 24
Brief: Creative Medical Technology Holdings Successfully Completes Enrollment And Treatment Across Entire FDA-Cleared Adapt Trial, Including Opioid Cohort, Advancing Celz-201 / Olastrocel Toward Rmat Evaluation And Phase 3 Planning
Creative Medical Technology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
NASDAQ RESUMED AT 11:07 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:02 AM